Show simple item record

dc.contributor.authorWang, Men
dc.contributor.authorRule, Sen
dc.contributor.authorZinzani, PLen
dc.contributor.authorGoy, Aen
dc.contributor.authorCasasnovas, Oen
dc.contributor.authorSmith, SDen
dc.contributor.authorDamaj, Gen
dc.contributor.authorDoorduijn, JKen
dc.contributor.authorLamy, Ten
dc.contributor.authorMorschhauser, Fen
dc.contributor.authorPanizo, Cen
dc.contributor.authorShah, Ben
dc.contributor.authorDavies, Aen
dc.contributor.authorEek, Ren
dc.contributor.authorDupuis, Jen
dc.contributor.authorJacobsen, Een
dc.contributor.authorKater, APen
dc.contributor.authorLe Gouill, Sen
dc.contributor.authorOberic, Len
dc.contributor.authorRobak, Ten
dc.contributor.authorJain, Pen
dc.contributor.authorFrigault, MMen
dc.contributor.authorIzumi, Ren
dc.contributor.authorNguyen, Den
dc.contributor.authorPatel, Pen
dc.contributor.authorYin, Men
dc.contributor.authorDługosz-Danecka, Men
dc.date.accessioned2021-09-20T12:54:13Z
dc.date.issued2019-09-26en
dc.identifier.issn0887-6924en
dc.identifier.urihttp://hdl.handle.net/10026.1/17870
dc.format.extent2762 - 2766en
dc.languageenen
dc.language.isoenen
dc.publisherSpringer Nature [academic journals on nature.com]en
dc.titleDurable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphomaen
dc.typeJournal Article
plymouth.issue11en
plymouth.volume33en
plymouth.journalLeukemiaen
dc.identifier.doi10.1038/s41375-019-0575-9en
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dcterms.dateAccepted2019-07-19en
dc.rights.embargodate2021-09-21en
dc.identifier.eissn1476-5551en
dc.rights.embargoperiodNot knownen
rioxxterms.versionofrecord10.1038/s41375-019-0575-9en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2019-09-26en
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV